Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines. | Prog Biophys Mol Biol | 2023 | 36801471 | PubTator, text mining | PubMed |
| Inflammation and autoimmune myasthenia gravis. | Front Immunol | 2023 | 36793733 | PubTator, text mining | PubMed |
| Challenges and future of HER2-positive gastric cancer therapy. | Front Oncol | 2023 | 36793592 | PubTator, text mining | PubMed |
| A proteogenomic view of Parkinson's disease causality and heterogeneity. | NPJ Parkinsons Dis | 2023 | 36774388 | PubTator, text mining | PubMed |
| Proteomic characterization of atopic dermatitis blood from infancy to adulthood. | J Am Acad Dermatol | 2023 | 36773824 | PubTator, text mining | PubMed |
| Epidermolysis Bullosa Acquisita-Current and Emerging Treatments. | J Clin Med | 2023 | 36769788 | PubTator, text mining | PubMed |
| sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis. | Int J Mol Sci | 2023 | 36768661 | PubTator, text mining | PubMed |
| Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution. | Cancers (Basel) | 2023 | 36765855 | PubTator, text mining | PubMed |
| Integrative analysis of single-cell transcriptomics reveals age-associated immune landscape of glioblastoma. | Front Immunol | 2023 | 36761752 | PubTator, text mining | PubMed |
| A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis. | Nat Commun | 2023 | 36754962 | PubTator, text mining | PubMed |
| Genetic variations in low-to-medium-affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort. | Int J Immunogenet | 2023 | 36754570 | PubTator, text mining | PubMed |
| Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination. | J Gastric Cancer | 2023 | 36751001 | PubTator, text mining | PubMed |
| FcγRIIIA activation-mediated up-regulation of glycolysis alters MDSCs modulation in CD4+ T cell subsets of Sjögren syndrome. | Cell Death Dis | 2023 | 36746935 | PubTator, text mining | PubMed |
| Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha. | Cancer Discov | 2023 | 36745048 | PubTator, text mining | PubMed |
| LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors. | Front Immunol | 2023 | 36742309 | PubTator, text mining | PubMed |
| Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy. | ESMO Open | 2023 | 36731326 | PubTator, text mining | PubMed |
| Significant response to margetuximab in Chinese HER2-positive metastatic breast cancer patient who progressed after second-line targeted therapy. | Anticancer Drugs | 2023 | 36729856 | PubTator, text mining | PubMed |
| The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy. | MAbs | 2023 | 36727218 | PubTator, text mining | PubMed |
| Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults. | Geroscience | 2023 | 36720768 | PubTator, text mining | PubMed |
| CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. | Mol Cancer | 2023 | 36717905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=29